Two Sigma Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-413,163
| Closed | -$913K | – | 3354 |
|
|
2023
Q2 | $913K | Buy |
413,163
+396,523
| +2,383% | +$822K | ﹤0.01% | 1994 |
|
|
2023
Q1 | $42.3K | Sell |
16,640
-2,714
| -14% | -$5.36K | ﹤0.01% | 2779 |
|
|
2022
Q4 | $36.2K | Sell |
19,354
-284,012
| -94% | -$708K | ﹤0.01% | 2626 |
|
|
2022
Q3 | $780K | Buy |
303,366
+208,911
| +221% | +$520K | ﹤0.01% | 1575 |
|
|
2022
Q2 | $182K | Buy |
94,455
+49,571
| +110% | +$108K | ﹤0.01% | 2181 |
|
|
2022
Q1 | $133K | Sell |
44,884
-26,029
| -37% | -$97.9K | ﹤0.01% | 2398 |
|
|
2021
Q4 | $318K | Buy |
70,913
+59,226
| +507% | +$281K | ﹤0.01% | 3611 |
|
|
2021
Q3 | $57K | Sell |
11,687
-156,098
| -93% | -$860K | ﹤0.01% | 4143 |
|
|
2021
Q2 | $1.14M | Sell |
167,785
-248,744
| -60% | -$2.01M | ﹤0.01% | 2359 |
|
|
2021
Q1 | $2.94M | Buy |
416,529
+98,208
| +31% | +$707K | 0.01% | 1401 |
|
|
2020
Q4 | $1.99M | Buy |
318,321
+77,872
| +32% | +$458K | 0.01% | 1492 |
|
|
2020
Q3 | $1.3M | Buy |
240,449
+116,236
| +94% | +$576K | ﹤0.01% | 1584 |
|
|
2020
Q2 | $648K | Buy |
+124,213
| New | +$552K | ﹤0.01% | 1826 |
|
|
2020
Q1 | – | Sell |
-123,202
| Closed | -$497K | – | 3997 |
|
|
2019
Q4 | $497K | Buy |
+123,202
| New | +$427K | ﹤0.01% | 2804 |
|
|
2019
Q2 | – | Sell |
-19,031
| Closed | -$102K | – | 3767 |
|
|
2019
Q1 | $102K | Sell |
19,031
-60,323
| -76% | -$390K | ﹤0.01% | 2895 |
|
|
2018
Q4 | $407K | Sell |
79,354
-76,184
| -49% | -$578K | ﹤0.01% | 2240 |
|
|
2018
Q3 | $1.51M | Buy |
+155,538
| New | +$1.57M | ﹤0.01% | 1680 |
|
|
2014
Q2 | – | Sell |
-1,017
| Closed | -$38K | – | 2397 |
|
|
2014
Q1 | $38K | Sell |
1,017
-2,474
| -71% | -$97.7K | ﹤0.01% | 1931 |
|
|
2013
Q4 | $140K | Buy |
3,491
+2,271
| +186% | +$96.4K | ﹤0.01% | 2054 |
|
|
2013
Q3 | $47K | Buy |
+1,220
| New | +$43.7K | ﹤0.01% | 1783 |
|
Two Sigma Investments's PRTK Position: Q3 2023 in Review
Two Sigma Investments sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 413,163 shares — an estimated $913K sold.
Two Sigma Investments first reported a position in PRTK in Q3 2013 and held it in 20 quarters. The position peaked at $2.94M in Q1 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Two Sigma Investments reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Two Sigma Investments sold 413,163 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $913K.
- Two Sigma Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2013 and held it in 20 quarters.
- Two Sigma Investments's Paratek Pharmaceuticals, Inc. position peaked at $2.94M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.